The Effect of Green Coffee Supplement on Glycemic Control, Inflammatory Index, Lipid Profile, and Anthropometry in Type II Diabetic Patients

Niloufar Moein, Zahra Moein Jahromi, Z. Mazloom, A. Zamani
{"title":"The Effect of Green Coffee Supplement on Glycemic Control, Inflammatory Index, Lipid Profile, and Anthropometry in Type II Diabetic Patients","authors":"Niloufar Moein, Zahra Moein Jahromi, Z. Mazloom, A. Zamani","doi":"10.35248/2155-9600.21.11.809","DOIUrl":null,"url":null,"abstract":"This study was conducted to determine the effects of green coffee supplementation on glycemic control, oxidative stress, lipid profile and anthropometry measurements in patients with type 2 diabetes. The present study is a randomized clinical trial. 60 diabetic patients were randomly divided into intervention and control groups. Patients received green coffee extract daily for 8 weeks 800 mg supplement capsule (two 400 mg capsules per day). The control group received two placebo capsules daily. The variables evaluated included demographic and anthropometry information, physical activity according to the IPAQ questionnaire, 24-hour food recall (beginning, half and end of the study) and lipid profile, fasting blood sugar, serum insulin, HOMA-IR and TAC before and at the end of the eighth week, it was evaluated in all patients. The mean body weight, Body Mass Index (BMI), and waist circumference at the beginning and end of the study did not differ significantly between the two groups (P-values<0.05). The mean fasting blood sugar in the coffee group at the end of the study was significantly reduced compared with the placebo group (P-value=0.0001). The mean serum insulin in the coffee group at the end of the study was significantly reduced compared with the placebo group (P-value=0.003). Moreover, the mean HOMA-IR at the end of the study in the coffee group was significantly reduced compared with the placebo group (P-value=0.003). LDL and total cholesterol in the coffee group at the end of the study were significantly reduced compared with the placebo group (P-values=0.003). The mean triglyceride at the end of the study was not significantly different in the coffee group (P-values=0.15). The mean TAC at the end of the study in the coffee group was significantly higher than the placebo group (P\u0002value=0.0001). To sum up, the use of green coffee supplement which reduced the fasting blood sugar and insulin sensitivity and improved the blood lipid profile and TAC in type 2 diabetic patients. But it had no effect on weight, waist circumference, Body Mass Index (BMI) and triglyceride levels. Green coffee supplement can be considered as an adjunct in the control of diabetes in patients.","PeriodicalId":16764,"journal":{"name":"Journal of Nutrition and Food Sciences","volume":"1 1","pages":"1-5"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Nutrition and Food Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/2155-9600.21.11.809","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

This study was conducted to determine the effects of green coffee supplementation on glycemic control, oxidative stress, lipid profile and anthropometry measurements in patients with type 2 diabetes. The present study is a randomized clinical trial. 60 diabetic patients were randomly divided into intervention and control groups. Patients received green coffee extract daily for 8 weeks 800 mg supplement capsule (two 400 mg capsules per day). The control group received two placebo capsules daily. The variables evaluated included demographic and anthropometry information, physical activity according to the IPAQ questionnaire, 24-hour food recall (beginning, half and end of the study) and lipid profile, fasting blood sugar, serum insulin, HOMA-IR and TAC before and at the end of the eighth week, it was evaluated in all patients. The mean body weight, Body Mass Index (BMI), and waist circumference at the beginning and end of the study did not differ significantly between the two groups (P-values<0.05). The mean fasting blood sugar in the coffee group at the end of the study was significantly reduced compared with the placebo group (P-value=0.0001). The mean serum insulin in the coffee group at the end of the study was significantly reduced compared with the placebo group (P-value=0.003). Moreover, the mean HOMA-IR at the end of the study in the coffee group was significantly reduced compared with the placebo group (P-value=0.003). LDL and total cholesterol in the coffee group at the end of the study were significantly reduced compared with the placebo group (P-values=0.003). The mean triglyceride at the end of the study was not significantly different in the coffee group (P-values=0.15). The mean TAC at the end of the study in the coffee group was significantly higher than the placebo group (Pvalue=0.0001). To sum up, the use of green coffee supplement which reduced the fasting blood sugar and insulin sensitivity and improved the blood lipid profile and TAC in type 2 diabetic patients. But it had no effect on weight, waist circumference, Body Mass Index (BMI) and triglyceride levels. Green coffee supplement can be considered as an adjunct in the control of diabetes in patients.
绿咖啡补充剂对II型糖尿病患者血糖控制、炎症指数、血脂和人体测量的影响
本研究旨在确定绿咖啡补充剂对2型糖尿病患者血糖控制、氧化应激、血脂和人体测量的影响。本研究为随机临床试验。60例糖尿病患者随机分为干预组和对照组。患者每天服用绿咖啡提取物800毫克胶囊(每天2粒400毫克胶囊),持续8周。对照组每天服用两粒安慰剂胶囊。评估的变量包括人口统计学和人体测量信息、根据IPAQ问卷进行的体力活动、24小时食物召回(研究开始、一半和结束)和血脂、空腹血糖、血清胰岛素、HOMA-IR和TAC,所有患者在第8周之前和结束时都进行了评估。研究开始和结束时,两组患者的平均体重、身体质量指数(BMI)和腰围差异无统计学意义(p值<0.05)。研究结束时,与安慰剂组相比,咖啡组的平均空腹血糖显著降低(p值=0.0001)。研究结束时,与安慰剂组相比,咖啡组的平均血清胰岛素显著降低(p值=0.003)。此外,与安慰剂组相比,咖啡组在研究结束时的平均HOMA-IR显着降低(p值=0.003)。研究结束时,与安慰剂组相比,咖啡组的低密度脂蛋白和总胆固醇显著降低(p值=0.003)。研究结束时,咖啡组的平均甘油三酯没有显著差异(p值=0.15)。研究结束时,咖啡组的平均TAC显著高于安慰剂组(P值=0.0001)。综上所述,使用绿咖啡补充剂降低了2型糖尿病患者的空腹血糖和胰岛素敏感性,改善了血脂和TAC。但它对体重、腰围、身体质量指数(BMI)和甘油三酯水平没有影响。绿咖啡补充剂可作为糖尿病患者控制的辅助手段。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信